Copyright
©The Author(s) 2021.
World J Crit Care Med. Sep 9, 2021; 10(5): 220-231
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.220
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.220
Antibiotic | Staphylococcus aureus, n (%) = 2 (5) | Coagulase negative Staphylococcus,n (%) = 6 (18) | Enterococcus, n (%) = 5 (15) |
Penicillin | 0/2 (0) | 0/6 (0) | 1/5 (20) |
Ampicillin | 1/5 (20) | ||
Erythromycin | 1/2 (50) | 0/6 (0) | 0/5 (0) |
Clinamycin | 1/2 (50) | 3/6 (50) | |
Trimethoprim sulphamethoxazole | 1/2 (50) | 1/6 (16) | |
Vancomycin | 2/2 (100) | 6/6 (100) | 2/5 (40) |
Cloxacillin | 1/2 (50) | 0/6 (0) | |
Tetracycline | 1/2 (50) | 3/6 (50) | |
Linazolid | 2/2 (100) | 6/6 (100) | 5/5 (100) |
Daptomycin | 2/2 (100) | 6/6 (100) | 5/5 (100) |
- Citation: Al-Khawaja S, Saeed NK, Al-khawaja S, Azzam N, Al-Biltagi M. Trends of central line-associated bloodstream infections in the intensive care unit in the Kingdom of Bahrain: Four years’ experience. World J Crit Care Med 2021; 10(5): 220-231
- URL: https://www.wjgnet.com/2220-3141/full/v10/i5/220.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v10.i5.220